adagrasib
mirati
['adagrasib', 'nsclc', 'in person', 'sclc']
 and our senior editor are enjoying a great discussion on the safety of adagrasib for advanced or metastatic #nsclc for those with a krasg12c mutation at #asco22. attending in person and want to discuss your presentation? message us for more information. 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.